美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BTD CAPITAL FUND

29.82

0.0000

成交量：- -

成交額：- -

市值：119.28萬

市盈率：- -

高：29.82

開：29.82

低：29.82

收：29.82

資料載入中...

總覽公司新聞公告

【中國銀河證券：下半年繼續看好創新藥，關注器械與服務增速回升】中國銀河證券指出，2025年下半年繼續看好創新藥，關注器械與服務增速回升。1）持續看好醫藥創新：下半年創新藥BD預計仍將持續，國內丙類目錄及商保政策有望推動估值繼續提升。2）醫藥投融資有望復甦：二級市場繁榮有望帶來一級市場投融資回升，CXO及上游景氣度向好。3）醫療器械有望觸底回升：招投標數據已開始回暖，以舊換新積壓需求逐步釋放。4）醫療服務增速有望迎拐點：全國DRG/DIP支付改革實現統籌區及符合條件醫療機構全覆蓋，眼科領域復甦信號顯現。5）醫藥消費靜待復甦：觀察國內刺激消費政策效果，預期有利於醫藥消費復甦，渠道庫存出清、終端需求回暖。投資建議上，2025年醫藥創新藥板塊估值修復顯著，下半年有望帶動其他板塊回暖，我們看好創新藥產業鏈、細分行業龍頭，關注醫藥消費復甦。

中國銀河證券指出2025年下半年繼續看好創新藥關注器械與服務增速回升。1）持續看好醫藥創新：下半年創新藥BD預計仍將持續

6月4日DRG/DIP概念上漲0.04%，板塊個股ST易聯眾、迪安診斷漲幅居前

Synthetix和Derive共同取消價值2700萬美元的收購協議

老齡化推動醫保支付方式改革提速，下一步重點是什麼

【美國基因技術公司23andMe申請破產保護，並尋求公司出售】當地時間3月23日，美國基因技術公司23andMe表示，已在美國申請破產保護並正尋求出售。該公司補充稱，已獲得約3500萬美元的債務人持有（DIP）融資承諾，並預計在出售過程中繼續運營。

【AH互動】A股三大指數小幅高開滬指微漲0.02% DRG/DIP、AI製藥等概念板塊漲幅居前

【DRG/DIP板塊異動走高創業慧康漲超10%】DRG/DIP板塊異動走高，創業慧康漲超10%，塞力醫療、衞寧健康、迪安診斷、萬達信息、國新健康等跟漲。

醫保DRG/DIP改革催生新機遇，商業醫療險差異化轉型升級正當時

深度丨集採之外，原研藥正在商保目錄中迎來“新生”

21世纪经济报道

【AH互動】A股三大指數全天震盪整理創業板指收跌1.43% DRG/DIP、MLOps等概念板塊跌幅居前

【A股收評】三大指數走強，DeepSeek概念持續高潮

【AH互動】A股大盤午後震盪上行滬指全日收漲0.56% DRG/DIP、DeepSeek等概念板塊漲幅居前

【AH互動】A股三大指數早盤震盪分化滬指半日漲0.31% DRG/DIP、DeepSeek等概念板塊漲幅居前

【DRG/DIP概念股衝高，思創醫惠、創業慧康漲超10%】DRG/DIP概念股衝高，思創醫惠、創業慧康漲超10%，華宇軟件、萬達信息、塞力醫療跟漲。

【DRG/DIP概念股午後拉昇，東華軟件、國新健康漲停】DRG/DIP概念股午後拉昇，東華軟件、國新健康漲停，衞寧健康、思創醫惠漲超10%，嘉和美康、迪安診斷跟漲。

DRG/DIP概念股持續拉昇，衞寧健康20cm漲停

经济观察网

兩部門：目標2025年底前所有省份要將省內異地住院直接結算費用納入就醫地按病種付費管理

更普惠、更高端？DRG/DIP改革下商業醫療險發展腳步不停

21世纪经济报道

【國家醫保局：DRG/DIP付費基本實現統籌地區全覆蓋】今天（17日），國家醫保局召開醫保部門“保障人民健康賦能經濟發展”主題新聞發佈會，國家醫保局有關負責人表示，2019年以來先後啓動了住院費用按病組（DRG）和病種分值（DIP）付費，目前DRG/DIP付費基本實現統籌地區全覆蓋，改革地區醫療機構行為更加規範，醫療服務效率提高，時間和費用消耗指數下降、平均住院日縮短，節省了患者就醫費用和時間成本，人民羣眾就醫獲得感增強，醫保基金總體保持平穩安全態勢，有效保障醫保基金羣眾“救命錢”。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DIP/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DIP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DIP\",,,,,undefined,":{"symbol":"DIP","market":"US","secType":"STK","nameCN":"BTD CAPITAL FUND","latestPrice":29.82,"timestamp":1750449600000,"preClose":29.82,"halted":0,"volume":0,"delay":0,"floatShares":40000,"shares":40000,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"06-20 16:00:00 EDT","open":29.82,"high":29.82,"low":29.82,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":29.82,"sharesOutstanding":40000,"nav":29.83,"aum":1193200,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DIP\",,,,,undefined,":{"symbol":"DIP","floatShares":40000,"roa":"--","roe":"--","lyrEps":0,"shares":40000,"dividePrice":0,"high":29.82,"amplitude":0,"preClose":29.82,"low":29.82,"week52Low":22.67,"pbRate":"--","week52High":30.02,"institutionHeld":0,"latestPrice":29.82,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":29.82,"prevYearClose":25.8482},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DIP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544468181","title":"【中國銀河證券：下半年繼續看好創新藥，關注器械與服務增速回升】中國銀河證券指出，2025年下半年繼續看好創新藥，關注器械與服務增速回升。1）持續看好醫藥創新：下半年創新藥BD預計仍將持續，國內丙類目錄及商保政策有望推動估值繼續提升。2）醫藥投融資有望復甦：二級市場繁榮有望帶來一級市場投融資回升，CXO及上游景氣度向好。3）醫療器械有望觸底回升：招投標數據已開始回暖，以舊換新積壓需求逐步釋放。4）醫療服務增速有望迎拐點：全國DRG/DIP支付改革實現統籌區及符合條件醫療機構全覆蓋，眼科領域復甦信號顯現。5）醫藥消費靜待復甦：觀察國內刺激消費政策效果，預期有利於醫藥消費復甦，渠道庫存出清、終端需求回暖。投資建議上，2025年醫藥創新藥板塊估值修復顯著，下半年有望帶動其他板塊回暖，我們看好創新藥產業鏈、細分行業龍頭，關注醫藥消費復甦。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544468181","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544468181?lang=zh_tw&edition=fundamental","pubTime":"2025-06-19 08:27","pubTimestamp":1750292839,"startTime":"0","endTime":"0","summary":"1）持续看好医药创新：下半年创新药BD预计仍将持续，国内丙类目录及商保政策有望推动估值继续提升。3）医疗器械有望触底回升：招投标数据已开始回暖，以旧换新积压需求逐步释放。4）医疗服务增速有望迎拐点：全国DRG/DIP支付改革实现统筹区及符合条件医疗机构全覆盖，眼科领域复苏信号显现。投资建议上，2025年医药创新药板块估值修复显著，下半年有望带动其他板块回暖，我们看好创新药产业链、细分行业龙头，关注医药消费复苏。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/19082751160894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DIP","09939","BK1515","09997","BK1564","BK1574","BK1222","BK0276","BK1161","159883","601881","06978","161027","BK1100","09996","06881","BK0188","BK1583","BK1147","CXO","159938","159992"],"gpt_icon":0},{"id":"2544181977","title":"中國銀河證券指出2025年下半年繼續看好創新藥關注器械與服務增速回升。1）持續看好醫藥創新：下半年創新藥BD預計仍將持續","url":"https://stock-news.laohu8.com/highlight/detail?id=2544181977","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544181977?lang=zh_tw&edition=fundamental","pubTime":"2025-06-19 08:26","pubTimestamp":1750292766,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159992","BK1515","BK1161","06881","CXO","09996","601881","BK0188","CXO.AU","BK0276","09939","BK1222","BK7095","06978","159883","DIP","161027","BK7504","BK1583","09997","BK1100","BK1564","159938","BK1147","BK1574"],"gpt_icon":0},{"id":"2540057334","title":"6月4日DRG/DIP概念上漲0.04%，板塊個股ST易聯眾、迪安診斷漲幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2540057334","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540057334?lang=zh_tw&edition=fundamental","pubTime":"2025-06-04 18:23","pubTimestamp":1749032594,"startTime":"0","endTime":"0","summary":"6月4日，截至收盘，DRG/DIP概念上涨0.04%，板块资金流出14047.76万。上涨个股家数11个，下跌个股家数7个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/04182350860278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","300244","BK0077","BK0146","BK0197","BK0133","BK0070","BK0042","BK0068","BK0236","BK0186","300096","DIP","BK0231","BK0114"],"gpt_icon":0},{"id":"2538121443","title":"Synthetix和Derive共同取消價值2700萬美元的收購協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2538121443","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538121443?lang=zh_tw&edition=fundamental","pubTime":"2025-05-26 13:56","pubTimestamp":1748238964,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 Synthetix 和 Derive 的贡献者共同撤回了一项价值 2700 万美元的交易提案，根据该提案，Synthetix 将收购去中心化期权平台 Derive（前身为 Lyra）。 Derive 团队指出：“经过深思熟虑的讨论和社区反馈，合并 Synthetix 和 Derive 的 SIP-415 和 DIP 提案已被相互撤回。”\n此前消息，Synthetix 提议以 2700 万美元的代币交换方式收购期权协议 Derive。（The Block）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/432131?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["DIP","SNX.USD.CC","SNX.USD.HKCC"],"gpt_icon":0},{"id":"2529633989","title":"老齡化推動醫保支付方式改革提速，下一步重點是什麼","url":"https://stock-news.laohu8.com/highlight/detail?id=2529633989","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529633989?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 19:58","pubTimestamp":1745495880,"startTime":"0","endTime":"0","summary":"　　医药服务供给侧规模扩大、需求推动下的医药费用快速增长、医保制度运行压力加大，凸显出医保支付方式改革的迫切性。　　我国65岁及以上的老年人口已达2.2亿，医疗需求的增加和医疗费用的攀升持续驱动我国医保支付方式改革进一步扩面、提质、增效。　　医保支付方式距离实现既定目标仅一步之遥。　　时隔三年，“深化医保支付方式改革”再次被写入政府工作报告中，是今年医保改革的一个“重头戏”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-04-24/doc-ineuhpwn2000418.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-24/doc-ineuhpwn2000418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1515","BK1161","09939","DIP"],"gpt_icon":0},{"id":"2521522677","title":"【美國基因技術公司23andMe申請破產保護，並尋求公司出售】當地時間3月23日，美國基因技術公司23andMe表示，已在美國申請破產保護並正尋求出售。該公司補充稱，已獲得約3500萬美元的債務人持有（DIP）融資承諾，並預計在出售過程中繼續運營。","url":"https://stock-news.laohu8.com/highlight/detail?id=2521522677","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521522677?lang=zh_tw&edition=fundamental","pubTime":"2025-03-24 13:10","pubTimestamp":1742793056,"startTime":"0","endTime":"0","summary":"当地时间3月23日，美国基因技术公司23andMe表示，已在美国申请破产保护并正寻求出售。该公司补充称，已获得约3500万美元的债务人持有（DIP）融资承诺，并预计在出售过程中继续运营。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/24131048978952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DIP"],"gpt_icon":0},{"id":"2518210253","title":"【AH互動】A股三大指數小幅高開 滬指微漲0.02% DRG/DIP、AI製藥等概念板塊漲幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2518210253","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518210253?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 09:29","pubTimestamp":1741570196,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股三大指数小幅高开，沪指微涨0.02%，深成指涨0.18%，创业板指涨0.26%。板块方面，DRG/DIP、AI制药、SPD等概念板块涨幅居前；ERP、国资云、腾讯云等概念板块受压居前。","market":"us","thumbnail":"https://static.szfiu.com/news/20200915/ZTMxNjQ3ZDUxMTYwMDE1MDQzMDE2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/ZTMxNjQ3ZDUxMTYwMDE1MDQzMDE2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954658","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","DIP","159982","01477","399300"],"gpt_icon":0},{"id":"2516694106","title":"【DRG/DIP板塊異動走高 創業慧康漲超10%】DRG/DIP板塊異動走高，創業慧康漲超10%，塞力醫療、衞寧健康、迪安診斷、萬達信息、國新健康等跟漲。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516694106","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516694106?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 09:58","pubTimestamp":1741053496,"startTime":"0","endTime":"0","summary":"DRG/DIP板块异动走高，创业慧康涨超10%，塞力医疗、卫宁健康、迪安诊断、万达信息、国新健康等跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04095848502824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0186","BK0114","BK0250","300451","BK0042","BK0058","BK0217","BK0137","000503","BK0129","300253","LU0405327148.USD","BK0097","LU0405327494.USD","BK0028","BK0146","603716","BK0070","300168","300244","BK0197","BK0236","BK0077","BK0055","BK0188","BK0231","BK0201","DIP","BK0020"],"gpt_icon":0},{"id":"2514159050","title":"醫保DRG/DIP改革催生新機遇，商業醫療險差異化轉型升級正當時","url":"https://stock-news.laohu8.com/highlight/detail?id=2514159050","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514159050?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 16:52","pubTimestamp":1740473524,"startTime":"0","endTime":"0","summary":"随着医保支付DRG/DIP改革全面铺开，对消费者就医方式和就医费用产生深远影响。与之相对是，医保政策的变化也倒逼定位为医保补充的商业医疗险做出改变。2024年以来，为适应DRG/DIP带来的市场需求变化，一些大热的百万医疗险进行不同程度的升级调整，包括产品保障责任、费率及用药保障等。换言之，过去几年医保实施DRG/DIP支付制度改革，医保“控费”推动商保发展，中端医疗险或受到消费者青睐。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.huanqiu.com/article/4LdD3eBrRrG","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_huanqiu","symbols":["DIP"],"gpt_icon":0},{"id":"2513728970","title":"深度丨集採之外，原研藥正在商保目錄中迎來“新生”","url":"https://stock-news.laohu8.com/highlight/detail?id=2513728970","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513728970?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 19:54","pubTimestamp":1740398040,"startTime":"0","endTime":"0","summary":"在我国多层次医疗保障体系下，医保通过“保基本、广覆盖”的原则为广大群众提供了基本的医疗保障。不过，随着人民生活水平的提升和医疗需求的不断释放，传统医保支付方式在控制医疗费用和资源利用上面临巨大挑战。　　此外，在DRG/DIP改革下，多家险企竞相布局中高端医疗险，覆盖特需医疗、外购药等场景，试图在医保“保基本”之外开辟差异化赛道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-02-24/doc-inemqtxe9922111.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-24/doc-inemqtxe9922111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["DIP"],"gpt_icon":0},{"id":"2510875109","title":"【AH互動】A股三大指數全天震盪整理 創業板指收跌1.43% DRG/DIP、MLOps等概念板塊跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2510875109","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510875109?lang=zh_tw&edition=fundamental","pubTime":"2025-02-11 15:19","pubTimestamp":1739258390,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股三大指数全天震荡整理，截至收盘，沪指跌0.12%，创业板指跌1.43%，深证成指跌0.69%。沪深两市全天成交额1.64万亿，较上个交易日缩量949亿。盘面上看，DRG/DIP、MLOps、SPD等概念板块跌幅居前，盲盒经济、珠宝首饰、拼多多等概念板块涨幅居前。预计科技行情将继续演绎，但随着交易行为的高度一致，分化不可避免，需要保持一份理性。国内方面，1月份官方制造业PMI重回荣枯线下方，而春节错月推升CPI，短期面临回落压力。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952907","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399001","399006","DIP","159982","399300"],"gpt_icon":0},{"id":"2510856032","title":"【A股收評】三大指數走強，DeepSeek概念持續高潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2510856032","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510856032?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 15:27","pubTimestamp":1739172456,"startTime":"0","endTime":"0","summary":"2月10日，三大指数走强，截至收盘，沪指涨0.56%，深成指涨0.52%，创业板涨0.44%，科创50指数涨1.76%，两市超3800只个股上涨，沪深两市今日成交额约1.73万亿元。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202502_1/309b396c-041c-412b-b354-c7f3fafda2d7.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202502_1/309b396c-041c-412b-b354-c7f3fafda2d7.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67a9aa68230829b95daa68ec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["DIP"],"gpt_icon":0},{"id":"2510588151","title":"【AH互動】A股大盤午後震盪上行 滬指全日收漲0.56% DRG/DIP、DeepSeek等概念板塊漲幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2510588151","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510588151?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 15:14","pubTimestamp":1739171658,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股大盘午后震荡上行，三大指数悉数收涨，截至收盘，沪指涨0.56%，创业板指涨0.44%，深证成指涨0.52%。沪深两市全天成交额1.73万亿，较上个交易日缩量2294亿。总体上看，个股涨多跌少，全市场超4100只个股上涨。盘面上看，DRG/DIP、DeepSeek、MLOps等概念板块涨幅居前，机器人执行器、人形机器人、银行等概念板块跌幅居前。招商证券认为，今年2-3月，仍然是经典的做多A股的时间窗口。股票类型选择方向，偏主题类方向尤其是AI应用将会成为下一个阶段市场重点进攻的方向，消费电子、传媒互联网、软件等领域与大模型应用相关、人形机器人落地相关的领域值得重点关注。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MjQ0NDBhMGEzMDA0ZDkzNGRmNmU3OTEzNTY1NzM0ODk3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjQ0NDBhMGEzMDA0ZDkzNGRmNmU3OTEzNTY1NzM0ODk3.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399300","DIP","159982"],"gpt_icon":0},{"id":"2510093840","title":"【AH互動】A股三大指數早盤震盪分化 滬指半日漲0.31% DRG/DIP、DeepSeek等概念板塊漲幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2510093840","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510093840?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 11:34","pubTimestamp":1739158465,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股三大指数早盘震荡分化，截至午间收盘，沪指涨0.31%，创业板指跌0.35%，深证成指跌0.1%。板块方面，DRG/DIP、DeepSeek、MLOps等概念板块涨幅居前，机器人执行器、人形机器人、光伏设备等概念板块跌幅居前。德意志银行表示，DeepSeek推出后，中国知识产权得到认可，中国在高附加值领域和供应链主导地位的范围正以前所未有的速度扩大。该报告认为，2025年将是中国企业在全球崛起的一年，中国股票估值折价的现象将消失。报告还表示，A股和港股的本轮反弹始于2024年，预计会在2025年延续并超过此前高点。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952799","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DIP","399300","159982"],"gpt_icon":0},{"id":"2510773800","title":"【DRG/DIP概念股衝高，思創醫惠、創業慧康漲超10%】DRG/DIP概念股衝高，思創醫惠、創業慧康漲超10%，華宇軟件、萬達信息、塞力醫療跟漲。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510773800","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510773800?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 09:43","pubTimestamp":1739151828,"startTime":"0","endTime":"0","summary":"DRG/DIP概念股冲高，思创医惠、创业慧康涨超10%，华宇软件、万达信息、塞力医疗跟涨。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/10094348040656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0041","BK0146","BK0058","BK0129","BK0188","LU0405327494.USD","BK0170","BK0012","300078","BK0114","BK0201","BK0214","LU0405327148.USD","BK0231","BK0067","603716","BK0028","BK0250","BK0030","BK0070","BK0055","BK0089","300451","DIP","300271","300168"],"gpt_icon":0},{"id":"2509768725","title":"【DRG/DIP概念股午後拉昇，東華軟件、國新健康漲停】DRG/DIP概念股午後拉昇，東華軟件、國新健康漲停，衞寧健康、思創醫惠漲超10%，嘉和美康、迪安診斷跟漲。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509768725","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509768725?lang=zh_tw&edition=fundamental","pubTime":"2025-02-07 13:09","pubTimestamp":1738904983,"startTime":"0","endTime":"0","summary":"DRG/DIP概念股午后拉升，东华软件、国新健康涨停，卫宁健康、思创医惠涨超10%，嘉和美康、迪安诊断跟涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/07130948008595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0030","BK0197","BK0058","BK0089","BK0114","002065","BK0196","300253","BK0097","BK0146","BK0214","BK0070","000503","BK0028","DIP","BK0020","BK0042","BK0132","BK0236","BK0186","BK0077","BK0170","BK0041","688246","BK0137","BK0231","BK0188","BK0067","300078","300244","BK0217"],"gpt_icon":0},{"id":"2509426081","title":"DRG/DIP概念股持續拉昇，衞寧健康20cm漲停","url":"https://stock-news.laohu8.com/highlight/detail?id=2509426081","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509426081?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 11:16","pubTimestamp":1738725360,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ DRG/DIP概念股持续拉升，卫宁健康20cm涨停，创业慧康、嘉和美康涨超10%，国新健康、思创医惠（维权）跟涨。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-02-05/doc-ineikxsp2188870.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-05/doc-ineikxsp2188870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0058","BK0077","BK0114","300253","DIP","BK0231","BK0188","BK0146","BK0020","BK0028"],"gpt_icon":0},{"id":"2506328434","title":"兩部門：目標2025年底前所有省份要將省內異地住院直接結算費用納入就醫地按病種付費管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2506328434","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506328434?lang=zh_tw&edition=fundamental","pubTime":"2025-01-27 16:12","pubTimestamp":1737965529,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，国家医保局会同财政部印发了《国家医保局办公室 财政部办公厅关于有序推进省内异地就医住院费用纳入按病种付费管理的通知》。2025年底前，所有省份要将省内异地住院直接结算费用纳入就医地按病种付费管理，包括按病组付费和病种分值付费两种形式。一是明确将省内异地就医住院费用统一纳入就医地按病种付费管理，参照就医地付费方式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["DIP"],"gpt_icon":0},{"id":"2504425247","title":"更普惠、更高端？DRG/DIP改革下商業醫療險發展腳步不停","url":"https://stock-news.laohu8.com/highlight/detail?id=2504425247","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504425247?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 13:48","pubTimestamp":1737352080,"startTime":"0","endTime":"0","summary":"自我国全面推进DRG/DIP支付方式改革，商业健康险如何适应新的医保支付方式就一直是业内热议的话题，对于商业健康险来说，DRG/DIP改革恰似一把双刃剑，机遇与挑战并存共生。　　众安保险健康险事业部资深产品专家王顺在接受21世纪经济报道记者采访时表示，DRG/DIP无疑是一项积极的政策，对民众降低整体医疗费用支出是有正向作用的。然而，对于商业保险而言，其就诊场景与资源发生了变化。　　2024年也是DRG/DIP支付方式改革三年行动计划的收官之年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-01-20/doc-inefrakc9024210.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-20/doc-inefrakc9024210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["DIP"],"gpt_icon":0},{"id":"2504977832","title":"【國家醫保局：DRG/DIP付費基本實現統籌地區全覆蓋】今天（17日），國家醫保局召開醫保部門“保障人民健康 賦能經濟發展”主題新聞發佈會，國家醫保局有關負責人表示，2019年以來先後啓動了住院費用按病組（DRG）和病種分值（DIP）付費，目前DRG/DIP付費基本實現統籌地區全覆蓋，改革地區醫療機構行為更加規範，醫療服務效率提高，時間和費用消耗指數下降、平均住院日縮短，節省了患者就醫費用和時間成本，人民羣眾就醫獲得感增強，醫保基金總體保持平穩安全態勢，有效保障醫保基金羣眾“救命錢”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2504977832","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504977832?lang=zh_tw&edition=fundamental","pubTime":"2025-01-17 10:33","pubTimestamp":1737081213,"startTime":"0","endTime":"0","summary":"今天（17日），国家医保局召开医保部门“保障人民健康 赋能经济发展”主题新闻发布会，国家医保局有关负责人表示，2019年以来先后启动了住院费用按病组（DRG）和病种分值（DIP）付费，目前DRG/DIP付费基本实现统筹地区全覆盖，改革地区医疗机构行为更加规范，医疗服务效率提高，时间和费用消耗指数下降、平均住院日缩短，节省了患者就医费用和时间成本，人民群众就医获得感增强，医保基金总体保持平稳安全态势，有效保障医保基金群众“救命钱”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/17103347541822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DIP"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DIP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-30","symbol":"DIP","reason":null,"defaultRemindTime":1717075800000,"announcedDate":"2024-05-14","type":"delisting","dateTimestamp":1717041600000},{"date":"2024-02-26","symbol":"DIP","amount":0.046657,"announcedDate":"2024-02-23","type":"dividend","market":"US","newRecordDate":"2024-02-27","defaultRemindTime":1708957800000,"name":"BTD CAPITAL FUND","recordDate":"2024-02-28","payableDate":"2024-02-27","currency":"USD","dateTimestamp":1708923600000,"payDate":"2024-02-28"},{"date":"2023-12-27","symbol":"DIP","amount":0.62974,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"BTD CAPITAL FUND","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"},{"date":"2023-11-28","symbol":"DIP","amount":0.00793,"announcedDate":"2023-11-27","type":"dividend","market":"US","newRecordDate":"2023-11-29","defaultRemindTime":1701181800000,"name":"BTD CAPITAL FUND","recordDate":"2023-11-30","payableDate":"2023-11-29","currency":"USD","dateTimestamp":1701147600000,"payDate":"2023-11-30"},{"date":"2023-10-27","symbol":"DIP","amount":0.018623,"announcedDate":"2023-10-26","type":"dividend","market":"US","newRecordDate":"2023-10-30","defaultRemindTime":1698413400000,"name":"BTD CAPITAL FUND","recordDate":"2023-10-31","payableDate":"2023-10-30","currency":"USD","dateTimestamp":1698379200000,"payDate":"2023-10-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DIP\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.071257,"currency":"USD"},{"executeDate":"2023-06-28","recordDate":"2023-06-29","paymentDate":"2023-06-30","value":0.016299,"currency":"USD"},{"executeDate":"2023-10-27","recordDate":"2023-10-30","paymentDate":"2023-10-31","value":0.018623,"currency":"USD"},{"executeDate":"2023-11-28","recordDate":"2023-11-29","paymentDate":"2023-11-30","value":0.00793,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.62974,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DIP\",market:\"US\",delay:false,,,undefined,":{}}}